Sulphamethoxazole + Trimethoprim is a combination antibiotic used to treat a variety of bacterial infections. This fixed-dose combination leverages the synergistic effects of two drugs to enhance antibacterial activity and reduce the potential for resistance.
This combination is used to treat:
| Brand Name | Sulphamethoxazole + Trimethoprim |
|---|---|
| Type | |
| Weight | |
| Generic | Sulphamethoxazole + Trimethoprim |
| Manufacturer | |
| Available in | English বাংলা |
Sulphamethoxazole and Trimethoprim work together to inhibit bacterial folic acid synthesis. Sulphamethoxazole is a sulfonamide that blocks the bacterial enzyme dihydropteroate synthase, preventing the formation of folate. Trimethoprim inhibits dihydrofolate reductase, another enzyme involved in folate synthesis. The combined inhibition of these pathways results in potent antibacterial activity.
Patients may start to feel improvement within a few days of starting treatment. Full therapeutic effects typically become evident within 7 to 10 days, depending on the type and severity of the infection.
Both Sulphamethoxazole and Trimethoprim are well absorbed from the gastrointestinal tract. Peak plasma concentrations are generally reached within 1 to 4 hours after oral administration.
Sulphamethoxazole is primarily metabolized in the liver and excreted via the kidneys. Trimethoprim is also metabolized in the liver and excreted mostly in the urine. Both drugs are eliminated primarily through the renal route.
The typical dosage for adults is:
For children, dosage is based on body weight and the specific infection being treated.
Take Sulphamethoxazole + Trimethoprim with or without food. It is generally recommended to take the medication at evenly spaced intervals to maintain effective drug levels in the body. Drink plenty of fluids to help prevent crystalluria (crystals in the urine).
Common side effects include:
Serious side effects may include:
Overdose may lead to toxicity, manifesting as severe gastrointestinal disturbances, central nervous system effects (e.g., dizziness, headache), or hematological abnormalities. In case of suspected overdose, seek immediate medical attention.
Use with caution in patients with:
Regular monitoring of blood counts and renal function may be required during prolonged therapy.
Interactions with other drugs may occur, including:
Use with caution in patients with:
Notable drug interactions include:
No significant food interactions are noted. However, avoiding excessive alcohol consumption may help reduce the risk of gastrointestinal side effects.
Sulphamethoxazole + Trimethoprim should generally be avoided during pregnancy, especially during the first trimester. Potential risks to the fetus include teratogenic effects. Consult a healthcare provider to assess the risks versus benefits.
Both Sulphamethoxazole and Trimethoprim are excreted in breast milk. The use of this medication during lactation should be carefully considered, and alternative treatments may be recommended if necessary.
In cases of acute overdose, seek medical attention immediately. Treatment may involve supportive care and symptomatic management, including hydration and monitoring for potential adverse effects.
Contraindications include:
Follow the prescribed dosage and administration guidelines. Do not use for longer than prescribed, and complete the full course of therapy even if symptoms improve. Contact your healthcare provider if symptoms persist or worsen.
Store at room temperature, away from moisture and heat. Keep the medication in its original container, tightly closed, and out of reach of children.
The volume of distribution for Sulphamethoxazole and Trimethoprim is approximately 0.2 to 0.3 L/kg for both drugs. These values may vary depending on individual patient characteristics.
The half-life of Sulphamethoxazole is approximately 10 hours, while the half-life of Trimethoprim is about 8 to 11 hours. The elimination half-life may be prolonged in patients with renal impairment.
Sulphamethoxazole and Trimethoprim are primarily cleared through renal excretion. Clearance rates may be reduced in patients with renal dysfunction, necessitating dose adjustments.
See in details version Sulphamethoxazole + Trimethoprim also Sulphamethoxazole + Trimethoprim in bangla
Prof. Dr. D. A. Hassan Chowdhury
General, Laparoscopic & Colorectal (Piles) Surgery Specialist